Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06100991 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

StatusRecruiting
PhaseNot specified
SponsorCorEvitas
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updatedv5
  2. Primary endpoints: 1 to 2
    • Secondary endpoints shortened, about 140 words
    v4
  3. Trial status: Enrolling by Invitation to Recruiting
    • Eligibility criteria expanded, about 38 words
    • Site details revised
    v3
  4. Secondary endpoints revised (19)v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
CorEvitas
24 trials monitored
See all monitored trials
Psoriasis
591 trials monitored
See 24 trials at risk
Prospective, observational registry for subjects with GPP under the care of a dermatology investigator.Approximately 200 subjects and 75 clinical sites in North America will be recruited to participate with no defined upper limit for either target
Trial Details
NCT Number NCT06100991
Lead Sponsor CorEvitas
Conditions
(from sponsor)		 Generalized Pustular Psoriasis
Related terms Psoriasis
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov